Traumatic Brain Injury induces persistent behavioural deficits that are rescued by the antiepileptic drug Levetiracetam
Traumatic Brain Injury (TBI) produces acute challenges including seizures and neuroinflammation, and these then exacerbate lifelong difficulties including epilepsy, dementias, and anxiety. Applying antiepileptic drugs (AED) to manage acute seizures after TBI has promise to slow these progressive deficits. Levetiracetam (LEV) is an AED that mitigates seizures and neuroinflammation in various…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
